Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s68386 ◽

2014 ◽

pp. 1851 ◽

Author(s):

Shaodong Hong ◽

Wenfeng Fang ◽

WENHUA LIANG ◽

Yue Yan ◽

Ting Zhou ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Endothelial Growth Factor ◽

Risk Of Treatment ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials

Annals of Oncology ◽

10.1093/annonc/mdt292 ◽

2013 ◽

Vol 24 (12) ◽

pp. 2943-2952 ◽

Author(s):

W.-X. Qi ◽

L.-N. Tang ◽

Y.-J. Sun ◽

A.-N. He ◽

F. Lin ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Hemorrhagic Events ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Risk of gastrointestinal events with newly approved (after 2011) vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized controlled trials

European Journal of Clinical Pharmacology ◽

10.1007/s00228-017-2299-y ◽

2017 ◽

Vol 73 (10) ◽

pp. 1209-1217 ◽

Author(s):

Jing Li ◽

Jian Gu

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Faculty of 1000 evaluation for Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718060934.793484591 ◽

2013 ◽

Author(s):

David Varon

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Hemorrhagic Events ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Faculty Opinions recommendation of Risk of gastrointestinal events with newly approved (after 2011) vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized controlled trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733648682.793548437 ◽

2018 ◽

Author(s):

Camilo Jimenez

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Cardiovascular Toxicities with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Meta-Analysis of 77 Randomized Controlled Trials

Clinical Drug Investigation ◽

10.1007/s40261-018-0709-2 ◽

2018 ◽

Vol 38 (12) ◽

pp. 1109-1123 ◽

Author(s):

Jing Li ◽

Jian Gu

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials

Expert Review of Clinical Pharmacology ◽

10.1080/17512433.2020.1734450 ◽

2020 ◽

Vol 13 (3) ◽

pp. 311-320 ◽

Author(s):

Wei Zhang ◽

Li-Jin Feng ◽

Fei Teng ◽

Yan-Hong Li ◽

Xi Zhang ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients

10.18632/oncotarget.11813 ◽

2016 ◽

Vol 7 (41) ◽

pp. 67661-67673 ◽

Author(s):

Bo Liu ◽

Fengxia Ding ◽

Yang Liu ◽

Geng Xiong ◽

Tao Lin ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s102265 ◽

2016 ◽

pp. 1167 ◽

Author(s):

Hao Wen ◽

Wufuer Yimaer ◽

Aizizi ABuDuReYiMu ◽

Ye Tian ◽

Sailike MaGaoWeiYa ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Advanced Thyroid Cancer ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

PLoS ONE ◽

10.1371/journal.pone.0090135 ◽

2014 ◽

Vol 9 (3) ◽

pp. e90135 ◽

Author(s):

Ze-Feng Zhang ◽

Tao Wang ◽

Li-Hua Liu ◽

Hui-Qin Guo

Keyword(s):

Systematic Review ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

The Lancet Oncology ◽

10.1016/s1470-2045(09)70222-0 ◽

2009 ◽

Vol 10 (10) ◽

pp. 967-974 ◽

Author(s):

Youjin Je ◽

Fabio AB Schutz ◽

Toni K Choueiri

Keyword(s):

Systematic Review ◽

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Risk Of Bleeding ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text